β3-adrenoceptor antagonist SR59230A attenuates the imbalance of systemic and myocardial oxygen transport induced by dopamine in newborn lambs

Clinical Medicine Insights: Cardiology

Volumn 6, Issue , 2012, Pages 45-51

  Gill, Richdeep S ^a   Cheung, Po Yin ^a   Yu, Xiaoyang ^a   Aklabi, Mohammed Al ^a   Quinonez, Jeevan Nagendran Luis G ^a   Li, Ying Qian ^a   Miller, John ^a   Ross, David B ^a   Rebeyka, Ivan M ^a   Li, Jia ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Newborn lambs; Oxygen consumption; SR59230A; 3 adrenoreceptors

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; DOPAMINE; LACTIC ACID; OXYGEN; PLACEBO;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ANIMAL EXPERIMENT; ARTERY BLOOD FLOW; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DRUG MECHANISM; HEART OUTPUT; HEART RATE; INOTROPISM; LAMB; MASS SPECTROMETRY; MYOCARDIAL OXYGEN TRANSPORT IMBALANCE; NEWBORN; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PULMONARY ARTERY FLOW; RECTUM TEMPERATURE; SYSTEMIC OXYGEN TRANSPORT IMBALANCE;

EID: 84863292025     PISSN: 11795468     EISSN: 11795468     Source Type: Journal    
DOI: 10.4137/CMC.S8654     Document Type: Article

References (25)

1. MacCannell KL, McNay JL, Meyer MB, Goldberg LI. Dopamine in the treatment of hypotension and shock. N Engl J Med. 1966;275:1389-98.
2. Crexells C, Bourassa MG, Biron P. Effects of dopamine on myocardial metabolism in patients with ischaemic heart disease. Cardiovasc Res. 1973;7:438-45.
3. Penny DJ, Sano T, Smolich JJ. Increased systemic oxygen consumption offsets improved oxygen delivery during dobutamine infusion in newborn lambs. Intensive Care Med. 2001;27:1518-25.
4. Bhatt SB, Hutchinson RC, Tomlinson B, Oh TE, Mak M. Effect of dobutamine on oxygen supply and uptake in healthy volunteers. Br J Anaesth. 1992;69:298-303.
5. Abdul-Rasool IH, Chamberlain JH, Swan PC, Ward DS. Cardiorespiratory and metabolic effects of dopamine and dobutamine infusions in dogs. Crit Care Med. 1987;15:1044-50.
6. Li J, Zhang G, Holtby H, et al. Adverse effects of dopamine on systemic hemodynamic status and oxygen transport in neonates after the Norwood procedure. J Am Coll Cardiol. 2006;48:1859-64.
7. Sell H, Deshaies Y, Richard D. The brown adipocyte: Update on its metabolic role. Int J Biochem Cell Biol. 2004;36:2098-104.
8. Arch JR, Kaumann AJ. Beta 3 and atypical beta-adrenoceptors. Med Res Rev. 1993;13:663-729.
9. Atgie C, D'Allaire F, Bukowiecki LJ. Role of beta1- and beta3-adrenoceptors in the regulation of lipolysis and thermogenesis in rat brown adipocytes. Am J Physiol. 1997;273:C1136-42.
10. Maxwell G, Crompton S, Smyth C. The effect of dopamine upon oxidative metabolism of brown fat adipocytes. Eur J Pharmacol. 1985;116:293-7.
11. Tan S, Curtis-Prior PB. Characterization of the beta-adrenoceptor of the adipose cell of the rat. Int J Obes. 1983;7:409-14.
12. Emorine LJ, Marullo S, Briend-Sutren MM, et al. Molecular characterization of the human beta 3-adrenergic receptor. Science. 1989;245:1118-21.
13. Bird JA, Mostyn A, Clarke L, et al. Effect of postnatal age and a beta(3)-adrenergic agonist (zeneca d7114) administration on uncoupling protein-1 abundance in the lamb. Exp Physiol. 2001;86:65-70.
14. Nisoli E, Tonello C, Landi M, Carruba MO. Functional studies of the first selective beta 3-adrenergic receptor antagonist sr 59230a in rat brown adipocytes. Mol Pharmacol. 1996;49:7-14.
15. Tonello C, Dioni L, Briscini L, Nisoli E, Carruba MO. Sr59230a blocks beta3-adrenoceptor-linked modulation of upcoupling protein-1 and leptin in rat brown adipocytes. Eur J Pharmacol. 1998;352:125-9.
16. Gan RT, Li WM, Xiu CH, et al. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure. Chin Med J (Engl). 2007;120:2250-5.
17. Li J, Zhang G, McCrindle BW, et al. Profiles of hemodynamics and oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure. J Thorac Cardiovasc Surg. 2007;133:441-8.
18. Gauthier C, Leblais V, Kobzik L, et al. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest. 1998;102:1377-84.
19. Kitamura T, Onishi K, Dohi K, Okinaka T, Isaka N, Nakano T. The negative inotropic effect of beta3-adrenoceptor stimulation in the beating guinea pig heart. J Cardiovasc Pharmacol. 2000;35:786-90.
20. Gauthier C, Seze-Goismier C, Rozec B. Beta 3-adrenoceptors in the cardiovascular system. Clin Hemorheol Microcirc. 2007;37:193-204.
21. Moens AL, Leyton-Mange JS, Niu X, et al. Adverse ventricular remodeling and exacerbated nos uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol. 2009;47:576-85.
22. Wheeldon NM, McDevitt DG, Lipworth BJ. Investigation of putative cardiac beta 3-adrenoceptors in man. Q J Med. 1993;86:255-61.
23. Wheeldon NM, McDevitt DG, Lipworth BJ. Cardiac effects of the beta 3-adrenoceptor agonist brl35135 in man. Br J Clin Pharmacol. 1994;37:363-9.
24. Tham EB, Khoo NS, Gauthier V, Inage A, Smallhorn JF. Abstract 1941: Changes in ventricular strain pattern in infants with hypoplastic left heart syndrome. Circulation. 2009;120:S576-b-7.
25. Vogel M, Derrick G, White PA, et al. Systemic ventricular function in patients with transposition of the great arteries after atrial repair: A tissue Doppler and conductance catheter study. J Am Coll Cardiol. 2004;43:100-6.